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Depletion of intracellular Ca2+ stores induces Ca2+ influx across the plasma membrane through store-operated channels (SOCs). This store-
operated Ca2+ influx is important for the replenishment of the Ca2+ stores, and is also involved in many signaling processes by virtue of the ability
of intracellular Ca2+ to act as a second messenger. For many years, the molecular identities of particular SOCs, as well as the signaling
mechanisms by which these channels are activated, have been elusive. Recently, however, the mammalian proteins STIM1 and Orai1 were shown
to be necessary for the activation of store-operated Ca2+ entry in a variety of mammalian cells. Here we present molecular, pharmacological, and
electrophysiological properties of SOCs, with particular focus on the roles that STIM1 and Orai1 may play in the signaling processes that regulate
various pathways of store-operated entry.
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oscillationCa2+ is an essential second messenger in virtually all cell
types, and it regulates a wide spectrum of events from
neurotransmission to gene transcription. Cytoplasmic Ca2+ can
be elevated in cells either by release from internal stores located
in the endoplasmic reticulum (ER) or by entry across the plasma
membrane [9]. In many cases, intracellular Ca2+ release and
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([Ca2+]i) are often necessary for proper signaling to occur.
A major mechanism of Ca2+ release involves the phosphoi-
nositide (PI) pathway, whereby plasma membrane receptors of
the G-protein-linked or tyrosine kinase families activate specific
phospholipase C (PLC) isoforms, resulting in the cleavage of
phosphatidylinositol 4,5-bisphosphate (PIP2) into diacylgly-
cerol (DAG) and inositol 1,4,5-trisphosphate (IP3). DAG is most
recognizable as an activator of protein kinase C (PKC), but can
also play a more direct role in regulating Ca2+ signal generation.
IP3 is a critical Ca
2+ releasing agent in the cell, and it achieves
this by activating the IP3 receptor (IP3R) located in the ER
membrane; binding of IP3 to its receptor results in the receptor/
channel opening and release of Ca2+ from the ER into the
cytoplasm [7].
Activation of the PI pathway also results in Ca2+ entry by 2
important mechanisms. First, second messengers generated
downstream of activation of the PI pathway, such as DAG,
arachidonic acid (AA), and Ca2+ itself [11], can directly activate
Ca2+ entry channels in the plasma membrane; these channels
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the release of Ca2+ from the ER induced by IP3 leaves the ER in
a state of Ca2+ depletion; this depletion of ER Ca2+ activates
plasma membrane Ca2+ entry [98], a process originally termed
capacitative calcium entry (CCE) [128], through channels
generally referred to as store-operated channels (SOCs). This
review will focus on Ca2+ entry through SOCs, covering the
most recent findings in the activation mechanisms of SOCs, the
pharmacological, electrophysiological, and molecular proper-
ties of SOCs, and physiological and pathophysiological roles
for SOCs. For more information on other modes of receptor-
regulated entry, the reader is referred to recent reviews [11,140].
1. Overview of store-operated entry
By definition, SOCs are activated exclusively as a result of
depletion of intracellular Ca2+ stores [86]. Experimentally, entry
through SOCs can be distinguished from other modes of Ca2+
entry by employing protocols that achieve ER Ca2+ depletion
independently of activation of other signaling pathways.
Paramount to the idea that SOC activation relies exclusively
on store depletion is the fact that the ER must be able to
communicate Ca2+ store depletion to SOCs within the plasma
membrane in some way.
The existence of SOCs was first postulated in 1986 [98].
Since then, the molecular nature of the process, i.e., the channels
responsible for the Ca2+ influx and the signaling mechanisms
that result in activation of the channels, has remained enigmatic.
It is important to note that store-operated entry does not
necessarily refer to a single mechanism of Ca2+ entry, nor does
SOC necessarily refer to a single Ca2+ entry channel; instead,
any channel that can be shown to exhibit Ca2+ store-dependent
activity can be referred to as a SOC. The most studied and best
characterized SOC current is the Ca2+ release-activated Ca2+
current, or ICRAC, which was first characterized in mast cells
[45,46], but has been measured in a variety of cells ranging from
T and B-lymphocytes to hepatocytes [85]. ICRAC is a non-
voltage-gated current, and is notable for its very high selectivity
for Ca2+, as indicated by its strong inward rectification, highly
positive reversal potential, and low conductance [85,86,97];
other store-operated entry currents that have been characterized
generally exhibit less stringent ionic selectivities and a variety of
conductances [85,86]. The mechanism by which ICRAC is
activated, including the molecular identity of the CRAC
channel, has long been the most sought-after signaling paradigm
in the store-operated entry field. For some time now, a significant
effort has beenmade to determine whether or not members of the
transient receptor potential (TRP) family of ion channels are
molecular components of the CRAC channel. Particular focus
has concentrated on the canonical TRPs (TRPCs), since it has
been shown that these ion channels are activated downstream of
PLC activation and, in some cases, can operate as SOCs (see
Section 5.1); however, as of yet, no TRPC channel has passed
the ultimate test—that is, the ability to fully recapitulate the
electrophysiological and pharmacological properties of ICRAC.
Nevertheless, it is important to note that TRP channels may
function in certain physiological contexts as SOCs, despite thefact that this activity is distinct from ICRAC. Now, the quest to
uncover the molecular identity of the ICRAC channel and its
mechanism of activation has come to an important new turning
point with the recent discoveries that two proteins, STIM1 and
Orai1, play obligatory roles in the activation of ICRAC. As will be
discussed in Section 4, accumulating evidence indicates that
STIM1 acts as a sensor of ER store content, while Orai1 may be
the ICRAC channel itself.
Regardless of its form, whether it be via ICRAC or another
SOC, store-operated Ca2+ influx accomplishes several critical
functions within the cell. First, Ca2+ that enters the cell via the
SOC pathway replenishes the ERCa2+ stores following a release
event, thus maintaining the ability of the ER to release Ca2+ into
the cytoplasm in response to subsequent Ca2+ releasing stimuli.
This is most notable in cells that respond to activation of the PI
pathway with [Ca2+]i oscillations, since ablation of Ca2+ entry
by removing extracellular Ca2+ or by other pharmacological or
molecular means will often times preclude a cell's ability to
maintain [Ca2+]i oscillations (see Section 6). Second, Ca
2+
concentrations within the ER must be maintained at sufficient
levels in order for the organelle to carry out many of its
fundamental functions. Thus, chronic depletion of ER Ca2+, as
would occur in the absence of store-operated Ca2+ entry, can
influence ER-dependent processes such as protein folding and
trafficking, the ER stress response, and apoptosis [20]. And
third, it should be noted that Ca2+ that enters the cell via the
store-operated pathway first accesses the cytoplasm before
entering the ER and, in many cases, results in sustained elevation
in [Ca2+]i levels. This is significant in that for some signaling
events, in particular T-lymphocyte activation, it is the increase in
cytoplasmic Ca2+ that results from store-operated entry, as
opposed to that which results from Ca2+ released from the ER,
that is responsible for signaling [54]. Thus, store-operated entry
can influence many aspects of cell biology, and it is vital that we
understand the molecular compositions of all forms of store-
operated entry so that we may fully appreciate its contribution to
normal physiological as well as pathophysiological states of
human health.
2. Pharmacology of store-operated entry
The use of pharmacological inhibitors of sarco/endoplasmic
reticulum Ca2+-ATPase (SERCA) pumps, which are responsible
for pumping Ca2+ into the lumen of the ER from the cytoplasm,
has been invaluable in the study of SOC function and regulation.
These compounds, which include thapsigargin, cyclopiazonic
acid and di-tert-butylhydroquinone, achieve Ca2+ store deple-
tion by allowing a constitutive passive leak of Ca2+ from the ER
to occur unchecked due to the inability of the inhibited SERCA
pumps to replenish the ER [21]. Further, ER depletion can be
effected by dialysis of cells with high concentrations of Ca2+
buffers such as EGTA or BAPTA, which effectively reduce the
free Ca2+ concentration in the cytosol available to the SERCA
pumps. Finally, direct buffering of ER Ca2+ with membrane
permeant N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylene diamine
(TPEN) reduces the free Ca2+ concentration in the ER and
activates store-operated entry. Hence, the pharmacological tools
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however, these tools do not allow for manipulation of the entry
process itself since they act on mechanisms that are upstream of
channel activation. In order to define roles for store-operated
entry in physiological processes, it is important to have available
tools by which one can predictably and specifically antagonize
the entry process. Unfortunately, the SOC field has chronically
been plagued by a lack of pharmacological inhibitors that
specifically target store-operated Ca2+ influx.
Currently available pharmacological inhibitors of the store-
operated entry pathway lack optimal specificity. Indeed, many
agents such as econazole and SK&F-96365 that are known to
inhibit SOCs were also noted to inhibit other ion channels,
particularly voltage-dependent channels, within the same
concentration ranges [34,99]. Another drug called 2-ami-
noethoxydiphenylborane (2-APB) described originally as an
IP3R antagonist [69], was shown later to be a direct inhibitor of
SOCs, having no effect on voltage-dependent Ca2+ entry
channels or arachidonic acid-activated Ca2+ channels
[2,15,96]. However, 2-APB was later shown to interfere with a
wide variety of transport mechanisms including SERCA pumps,
potassium channels and mitochondrial Ca2+ efflux (for review
see [86]). In addition, 2-APB has been found to activate TRPV1,
TRPV2 and TRPV3, members of the heat-gated vanilloid TRP
(TRPV) family of cation channels [23,47]. Despite these various
effects of 2-APB unrelated to store-operated entry, the drug
remains an important tool in the study of Ca2+ influx. Store-
operated entry and ICRAC in particular have the unique
characteristics of being potentiated by low concentrations of 2-
APB (1–5 μM), whereas they are inhibited by concentrations
greater than 10 μM [66,96]. And although the mechanism by
which 2-APB exerts these effects on SOCs is unknown, this
biphasic sensitivity to 2-APB is often used as a “fingerprint” that
helps define the store-operated nature of a particular Ca2+ influx
process.
There are other reagents that block store-operated entry but
also block voltage-dependent Ca2+ entry channels with equal
efficiencies. These drugs include L561582 [29,99], SC38249
[25,99], LU52396 [24,99] and tetrandine [53,99]. Other drugs
such as cytochrome P-450 inhibitors or reagents that inhibit
enzymes of arachidonic acid metabolism (cyclooxygenase and
lipoxygenase inhibitors) are also known to inhibit store-operated
entry (for review see [99]). However, these drugs are not specific
and their exact action on store-operated entry is not clear.
Themost reliable inhibitors of SOCs remain trivalents such as
La3+ and Gd3+. The latter when used at concentrations in the low
micromolar (1–5 μM) range has proven to be a specific blocker
of store-operated entry in many cell types without affecting
arachidonic acid-activated Ca2+ entry or the Ca2+ entry pathway
mediated by receptor-activated TRPC channels [17,63,135].
However, this inorganic inhibitor precipitates with divalent
anions and thus cannot be used in vivo. Its use is therefore
restricted to in vitro studies using cultured cells in media with
controlled compositions.
The quest for specific inhibitors of the various SOCs
expressed in human cells is clearly in its infancy and new drugs
that interfere with SOC activation are likely to be promisingtools for treatment of human diseases. The recent discovery of
STIM1 and Orai1 as important determinants in store-operated
entry is an important breakthrough toward our understanding of
the exact molecular identity and mechanism of activation of
SOCs. With further appreciation of the molecular makeup and
mechanism of activation of store-operated Ca2+ influx, we can
expect future developments of reagents that specifically target
this pathway.
3. Activation mechanisms of store-operated entry
At present there are 2 general hypotheses for the activation
mechanism of various store-operated entry pathways and of
ICRAC in particular: (i) action of a diffusible messenger that is
released from the ER to activate plasma membrane channels
upon ER Ca2+ depletion, and (ii) coupling between proteins
within the ER membrane with Ca2+ influx channels in the
plasma membrane [85,86]. In addition, there is speculation that
the activation mechanism may involve insertion of channels
into the plasma membrane [153] although some mechanism of
initiating the signaling from the ER would still be necessary.
There is evidence in support of these ideas in the literature;
however, much of this evidence is indirect and discrepancies
abound [86]. Direct proof of any of these activation mechanisms
as they relate to store-operated entry will likely only come as a
result of the identification of the molecular nature of individual
SOC channels.
3.1. Diffusible messenger
The diffusible messenger mechanism was recently the topic
of an extensive review [14] and will thus only be briefly
addressed here. The theory of a diffusible factor responsible
for activating store-operated entry was first implied by Putney
and colleagues [127], and evidence for the existence of such a
factor was first demonstrated by Randriamampita and Tsien
[103]. In this latter work the authors were successful in
isolating an acid-extractable factor from activated Jurkat T-
lymphocytes, referred to as Ca2+ influx factor (CIF), that was
capable of activating Ca2+ influx when applied to several
different cell types. Importantly, further biochemical purifica-
tion of CIF led to the resolution of a factor that was only
effective at evoking Ca2+ influx when microinjected into cells
[50,131], and thus acted upon an intracellular target. Another
significant boost to the CIF story came when it was shown
that a biochemically and functionally similar factor could also
be isolated from Saccharomyces cerevisiae in which the Ca2+-
ATPase gene pmr1 is mutated, resulting in depletion of
intracellular Ca2+ stores [26]; thus, CIF production is
apparently not specific to a single cell type or species. This
study was also the first to show a positive effect of CIF on the
development of ICRAC [26]. The mechanism by which CIF
activates Ca2+ influx remains unclear, although recent work
suggests a role for Ca2+-independent phospholipase A2
(iPLA2). It was first shown by pharmacological and molecular
approaches that inhibition of iPLA2 activity results in
suppression of SOC activity [41,112,120]. Smani et al. [119]
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entry by displacing an inhibitory calmodulin from iPLA2, and
that lysophospholipid generated by iPLA2 is responsible for
directly activating SOC channels. However, the exact
mechanism by which CIF activates SOC and whether it
constitutes the physiological activation signal for ICRAC awaits
the identification of the molecular entity of CIF.
3.2. Conformational coupling
The conformational coupling hypothesis, first proposed by
Irvine [48] and further developed by Berridge [8], draws
analogy to excitation–contraction coupling in skeletal muscle
whereby the dihydropyridine-sensitive Ca2+ channel in the
plasma membrane directly couples with the type 1 ryanodine
receptor in the sarcoplasmic reticulum. In the case of store-
operated entry, it was proposed that the IP3R in the ER
membrane directly links with putative Ca2+ entry channels in
the plasma membrane, and that a conformational change of the
IP3R upon ER Ca
2+ depletion signals the opening of SOC
channels. This hypothesis was revised somewhat by Patterson
et al. [88] into what has come to be known as the secretion-
like coupling model. This secretion-like coupling model
differs from the original conformational coupling model in
that the former allows for separation between IP3Rs and SOCs
when stores are full, and in response to store depletion the ER,
or specific subdomains of the ER, move close to the plasma
membrane and allow the interaction to occur between the IP3R
and SOCs. The most direct evidence for such a mechanism
comes from studies demonstrating that stabilization of a
cortical ring of actin with agents such as jasplakinolide or
calyculin A prevents the activation of store-operated entry
[88,111], the idea being that this ring of actin prevents the
movement of the ER toward the plasma membrane. However,
a subsequent exhaustive study in RBL-1 cells failed to
demonstrate any effects of cytoskeletal alterations on the
development of ICRAC [2]; a similar lack of dependence of
store-operated entry on the cytoskeleton had also been
previously demonstrated in NIH-3T3 cells [106]. Thus, cell-
type differences appear to be important considerations in the
conclusions drawn from experiments that evaluate the effects
of the cytoskeleton on store-operated entry. Evidence in favor
of conformational coupling between the IP3R and SOC
channels was also gleaned from early studies showing that
2-APB, thought at the time to be a specific IP3R inhibitor [69],
prevents thapsigargin-induced Ca2+ entry in HEK293 cells
[64]. It was subsequently shown that this drug also inhibits the
development of ICRAC in Jurkat and RBL cells [2,15,16,96].
However, these effects of 2-APB on store-operated entry can
no longer be taken as proof of involvement of the IP3R, since
it was later shown that 2-APB has direct inhibitory effects on
CRAC channels independently of antagonism of the IP3R
[2,15,96]. Most significantly, it was shown that 2-APB is
equally effective at inhibiting store-operated entry and ICRAC in
a DT40 B-cell line in which all 3 isoforms of the IP3R had
been genetically ablated, as compared to its inhibitory effect in
wild type DT40 cells [15,65]. And in fact the finding that Ca2+entry and ICRAC develop normally in these IP3R knockout cells
[125] provides the strongest evidence yet to indicate that
interaction of Ca2+ influx channels with the IP3R is not
required for the activation of ICRAC. However, this does not
preclude the idea that other proteins within the ER membrane
may conformationally couple with CRAC channels and
achieve ICRAC activation. Significantly, it has recently been
shown that STIM1 may act as such a factor, since it has been
shown that STIM1 is able to sense Ca2+ store levels within the
ER lumen, and undergoes a major relocalization toward the
plasma membrane in response to Ca2+ store depletion
[59,110,123,157], as will be addressed in Section 4. Thus,
STIM1 may act as the conformational coupler between the ER
and CRAC channels, an idea that has been addressed in a
recent review [43], and the conformational coupling literature
may now need to be readdressed in the context of STIM1
(discussed below).
3.3. Vesicle fusion
The vesicle fusion hypothesis postulates that vesicles
containing functional SOCs fuse with the plasma membrane
upon store depletion, resulting in plasma membrane insertion
of active channels. Evidence in support of this mechanism
comes from experimental strategies whereby ICRAC or Ca
2+
influx are measured under conditions in which exocytosis or
vesicle fusion should be impaired. For example, it was shown
that pharmacological or molecular interference with SNAP-25,
a member of the soluble N-ethylmaleimide-sensitive factor
attachment protein receptor (SNARE) complex, antagonizes
store-operated currents in Xenopus oocytes [153]. It was also
shown in HEK 293 cells that botulinum and tetanus
neurotoxins, which disrupt SNAP-25 and vesicle-associated
membrane protein 2 (VAMP-2), respectively, significantly
reduced store-depletion-activated Ca2+ entry [1]. However,
another study challenged the interpretation of these findings
[114]. An important caveat of all studies examining the roles
of vesicle trafficking is that it is difficult to distinguish from
such studies a role for induced exocytosis in response to store
depletion, as is required by the fusion hypothesis, from
disruption of constitutive exocytosis which is necessary to
maintain the normal complement of membrane components
for SOC function. Furthermore, it will be impossible to
directly demonstrate store-driven exocytosis of a CRAC
channel until the molecular identity of this channel is
known. Interestingly, in the case of TRPC channels, several
reports have demonstrated that agonists that activate channel
activity also result in exocytotic insertion of these channels
[10,22,81,84,118], thus further supporting the idea that
exocytosis may play an important role in Ca2+ entry
mechanisms. However, others have failed to observe such
increases in membrane expression of TRPC channels in
response to activating maneuvers [115,121]. And, as will be
discussed in Section 5, it remains unclear whether TRP
channels mediate physiological store-operated entry, and in all
of the instances cited above, TRP channels were activated by
means other than store depletion.
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Through the use of RNAi technology, two proteins have
recently been identified that are necessary for store-operated
entry and ICRAC in particular. The first of these proteins was
identified simultaneously by two separate groups using RNAi in
Drosophila S2 cells [110] and in human HeLa cells [59]. Each
group found that when the messages for the proteins Stim in
Drosophila or STIM1 in mammalian cells were targeted using
siRNA, cells were unable to activate Ca2+ entry following store
depletion using thapsigargin.
STIM1 was identified in limited screens using bioinformatics
to identify genes with probable ion channel or signaling
functions. However, the second protein, termed Orai or
CRACM, bears no resemblance or homology to any other
functional protein; thus it is not surprising that its discovery
came somewhat later, resulting from RNAi screens of the entire
Drosophila genome [33,143,156]. In the first publication
describing this protein, its identification was facilitated by the
finding that this particular gene was also the genetic cause of a
rare form of severe combined immunodeficiency (SCID)
[32,33]. The identification of these two proteins has revitalized
the quest to understand the mechanisms controlling ICRAC.
4.1. STIM1
Roos et al. performed a large scale RNAi screen in Droso-
phila S2 cells by targeting any protein with a transmembrane
domain, including the TRP channel family, as well as any protein
that had been previously described as playing a role in store-
operated entry [110]. Of 170 genes targeted, only Stim was
found to be needed for store-operated entry and activation of
ICRAC in S2 cells. In a parallel study Liou et al. targeted a total of
2304 proteins. They identified two mammalian Stim homo-
logues, STIM1 and STIM2, whose knockdown reduced store-
operated entry [59]. It should be noted that when Roos et al.
applied siRNAs against STIM1 and STIM2 in Jurkat cells,
STIM1 was essential for store-operated entry whereas loss of
STIM2 had no effect [110]. Perhaps the discrepancy between
these two results is due to off target effects of the siRNA used in
the Liou study, which was prepared by incubating the mRNA for
the respective proteins with the protein Dicer and then treating
cells with the processed RNA [59]. It is conceivable that one or
more pieces of the dicer-processed STIM2 RNA bore significant
homology to the STIM1 message. These reports also showed
that while treatment of cells with siRNA against STIM1
abolishes store-operated entry, it has no apparent effect on the
intracellular Ca2+ store content or the resting cytosolic Ca2+
concentration [59,110,123].
STIM1 is a type 1a single-pass transmembrane protein
[68,146]. It contains several conserved domains, including a
sterile-alpha motif (SAM), a coiled coil region, and an EF-
hand domain. Interestingly, neither the SAM nor the EF-hand
domains bear full resemblance to their respective consensus
domains. The SAM domain contains two N-linked glycosyl-
ation sites, making it the first glycosylated SAM domain to be
identified [68,146]. EF-hand domains normally occur in pairs;however STIM1 only has one. There is some evidence to
suggest that STIM1 can homodimerize or heterodimerize with
STIM2, and this could bring together the EF-hands from
separate molecules to form an intermolecularly paired EF-
hand domain [146]. Due to the presence of the putative EF-
hand domain and the unlikely prospect of a channel protein
containing only one transmembrane domain, STIM1 is
thought to be the Ca2+ store-sensing component of the
ICRAC pathway as opposed to the CRAC channel itself. In
agreement with this prediction, mutations in acidic residues
within the Ca2+ binding pocket of the EF-hand domain of
STIM1, which presumably lower the affinity for Ca2+,
produce constitutive Ca2+ entry that is independent of store
depletion [59,157]. Additionally, wild-type STIM1 expressed
as a fusion with enhanced yellow fluorescent protein (EYFP-
STIM1) co-localized at least partially with a marker for ER
but rapidly rearranged into punctate structures following store
depletion [59]. EF-hand mutants of EYFP-STIM1 that confer
constitutive Ca2+ entry also appear constitutively in punctate
structures, indicating that Ca2+ binding is important for the
localization of STIM1 [59]. However, without physical
evidence of actual Ca2+ binding, it must be considered that
the EF-hand domain of STIM1 might not bind Ca2+ and could
serve another purpose.
There is some debate as to the cellular localization of STIM1
following store depletion. Several groups have reported
detection of STIM1 on the cell surface [68,123,146,157].
However, others have failed to detect any STIM1 in the plasma
membrane [59,73]. Additionally, while Zhang et al. [157]
reported a significant increase in plasma membrane STIM1
following store depletion, Spassova et al. [123] reported no such
increase. BothManji et al. [68] andWilliams et al. [146] reported
plasma membrane STIM1, but store depletion was not evaluated
in these studies because STIM1 was not known to be involved in
store-operated entry at the time. Thus, a portion of cellular
STIM1 may be inserted into the plasma membrane, but it is
unclear if those STIM1 molecules are important for activation of
ICRAC.
Although it is clear that STIM1 is a necessary component of
ICRAC and store-operated entry, the mechanism by which it acts
is still a mystery. Three preliminary models have been proposed
to explain how STIM1 might work based upon its cellular
localization patterns. All three models have in common that
STIM1 is located in the ER membrane prior to store depletion.
The first model suggests that STIM1 in the ER complexes with
STIM1 in the plasma membrane following store depletion
[110]. This model of course requires that some STIM1 is found
in the plasma membrane, and that this pool of STIM1 is
necessary for activation of ICRAC. The second model contends
that most or all STIM1 is confined to the ER membrane prior to
store depletion. After store depletion however, STIM1 (which is
presumably no longer bound to Ca2+) is somehow transported to
and inserted into the plasmamembrane [157]. It is not clear what
mechanism would be involved in the transport of STIM1 to the
plasma membrane, as accumulating evidence suggests that the
most likely mechanism, vesicle trafficking, is not involved in
ICRAC [2,86]. Both the first and second models are supported by
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[123,157]. However, these data must be interpreted with caution
since STIM1 may have been co-precipitated with a cell surface
protein such as the channel itself rather than being directly
biotinylated. In studies employing transfection of HEK293 cells
with STIM1 and Orai1 (discussed in the following section), no
STIM1 was detected in the plasma membrane by antibody
binding, despite the generation of huge STIM1- and Orai1-
dependent Icrac-like currents [73]. These latter findings favor a
third model which places STIM1 only in the ERmembrane [59].
Following store depletion, the punctae seen with EYFP-STIM1
would be very close to the cell surface, but not actually inserted
into the plasma membrane. In this scenario the cytosolic C-
terminus of STIM1 would interact with additional components
of the ICRAC pathway, such as the channels themselves, when
brought into the punctae. This model does not exclude the
possibility that STIM1 under certain circumstances can be
found in the plasma membrane. It does indicate however that
this putative plasma membrane pool of STIM1 is not essential
for activation of ICRAC and store-operated entry.
4.2. Orai1
The second protein component of ICRAC that has been
identified was named Orai after the Greek mythological
characters the Orai which are the keepers of the gates of heaven
[33]. In a report following close thereafter, the name CRACM
(for CRAC-Membrane) was suggested [143]. We will use the
Orai designation in deference to the first published description of
this protein. In addition to Orai1, there are two other Orai family
members, Orai2 and Orai3, expressed in mammals [33]. Flies
andworms express only oneOrai homolog, and this proteinmost
closely resembles the mammalian Orai1 [33]. Orai1 was first
identified from genetic linkage analysis performed to identify
mutations contributing to a rare form of severe SCID
characterized by a lack of ICRAC activity, combined with a
genome-wide screen inDrosophila to search for genes necessary
for nuclear translocation of the Ca2+-dependent transcription
factor NFAT [32,33]. Orai was identified as essential for Ca2+
entry inDrosophila, and the role of human Orai1 was confirmed
by sequencing the Orai1 gene from the SCID patients as well as
21 of their relatives. In addition to the two SCID patients, 13 of
the relatives had lower ICRAC activity in their T cells and were
predicted to be heterozygous carriers of the mutation [33].
Importantly, all 13 heterozygous family members as well as the 2
SCID patients carried the same arginine to tryptophan mutation
at amino acid position 91 in Orai1 [33]. This mutation was
confirmed to block ICRAC by its failure to rescue the lack of Ca
2+
entry and ICRAC activity when transfected into T cells and
fibroblasts from the SCID patients, whereas transfection of the
wild-type version did rescue [33].
Orai1, as well as the related Orai2 and Orai3, are predicted to
be membrane spanning proteins with 4 transmembrane domains
[33,143,156]. Unlike STIM1, Orai1 apparently resides only at
the plasma membrane [33,143]. With the exception of the
transmembrane segments, these proteins have no other readily
identifiable modular domains. Shortly following the report ofthe role of Orai1 in the human SCID patients, Vig et al. also
identified Drosophila Orai as an essential component of ICRAC,
although they called it CRACM1 [143]. In addition to Orai, Vig
et al. [143] identified another membrane component that they
termed CRACM2; however there is no human ortholog of
CRACM2 and so it appears not to be a conserved component of
the ICRAC pathway. Subsequently, several reports have
demonstrated a remarkable amplification of ICRAC (50–100
fold) when Orai1 is coexpressed with STIM1 [90,122,156].
This amplification is not seen when STIM1 alone is transfected
into cells. When Orai1 alone is transfected, there is a clear
inhibition of ICRAC in Jurkat [90], RBL [122] cells and HEK293
cells [73] (but see [90]). These findings illustrate several
important points. First, they demonstrate that STIM1 and Orai1
are the only components necessary to produce large ICRAC
currents when overexpressed, indicating that there are no other
rate-limiting components of the system (unless unknown
endogenous components are upregulated by the overexpression
conditions). Interestingly, the ICRAC currents observed when
STIM1 and Orai1 are coexpressed do not completely recapit-
ulate all of the canonical characteristics of ICRAC. Most notably,
the amplified currents have low permeability for Ba2+ and Sr2+
[143], both of which are known to pass readily through native
ICRAC channels although to a lesser extent than Ca
2+ [163]. This
could indicate that other protein components are found in native
ICRAC channels, such as the other Orai family members, that are
not necessary for activation and Ca2 permeation, but that
modulate some of the other pore properties. Second, the finding
that Orai1 overexpression alone results in inhibition of ICRAC
suggests Orai1 interacts with at least two other similarly
limiting components of the SOC pathway, perhaps STIM1
itself. Thus when excess Orai1 is present, the statistical
likelihood of combining in an appropriate stoichiometric
fashion with these other limiting components is reduced,
reducing the number of correctly assembled signaling com-
plexes [101]. Third, the observation that overexpression of these
two proteins produces such a dramatic increase in ICRAC current
density argues (but does not prove) that Orai1 may be the ICRAC
pore-forming unit. If Orai1 were merely another part of the
activation machinery then overexpression of STIM1 plus Orai1
might result in a small increase in current density, but only to the
point at which the endogenous channels are all in the open state.
Especially in HEK293 cells which have nearly undetectable
endogenous ICRAC, the likelihood of the cells expressing
enough endogenous channels to accommodate such large
increases in current density seems unlikely.
Mercer et al. [73] reported that Orai2 exhibits properties
similar to Orai1; i.e., overexpression of Orai2 alone resulted in
inhibition of store-operated Ca2+ entry in HEK293 cells,
whereas its coexpression with STIM1 resulted in significantly
augmented entry and ICRAC. The magnitude of the currents with
Orai2 were somewhat less than for Orai1, however. Orai3, on
the other hand, did not synergistically enhance Ca2+ entry when
coexpressed with STIM1. However, Orai3 was shown to restore
Ca2+ entry in cells in which entry was reduced due to RNAi-
mediated knockdown of endogenous Orai1, demonstrating that
Orai3 is able to function in the Ca2+ permeation pathway. Thus,
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of Orai family members appeared to be Orai1>Orai2>Orai3
[73].
Our developing appreciation of the critical roles that STIM1
and Orai1 play in the regulation of ICRAC will undoubtedly
revolutionize the field of store-operated entry. However, it must
be kept in mind that ICRAC may be only one species of store-
operated entry that operates physiologically in mammalian
cells. Therefore, it is important that we continue to examine
other store-operated entry pathways, such as those potentially
mediated by TRP channels and other, possibly undiscovered
channels. Additionally, it will be interesting to determine
whether STIM and Orai isoforms influence store-operated entry
pathways that are distinct from ICRAC.
5. TRP proteins as SOCs
For over a decade, members of the superfamily of TRP
proteins, particularly those from the mammalian TRPC family,
have been considered molecular candidates of SOCs. Based on
amino acid homology, the TRP superfamily includes at present
seven families: the TRPC (Canonical; TRPC1–TRPC7), the
TRPV (Vanilloid; TRPV1–6), and the TRPM (Melastatin;
TRPM1–8) families, and other more distantly related members,
like the TRPML (Mucolipin) and TRPP (Polycystin) families,
which although not yet well characterized, have received
increasing attention due to their association with several
inherited human diseases. More recently, the TRPA (Ankyrin)
group, with only one mammalian member, and the TRPN (no
mechanoreceptor potential C) group, only found in Caenor-
habditis, Drosophila and zebra fish, have been incorporated
into the TRP superfamily (reviewed in [89,102]). Recognition
of the product of the Drosophila trp gene as the Ca2+ permeable
channel underlying light-induced, PLC-dependent Ca2+ entry in
fly photoreceptor cells (reviewed in [77]), was rapidly followed
by cloning of several mammalian trp counterparts, TRPC1 and
TRPC3 being the first to be cloned and expressed in cell lines
[13]. Immediately thereafter, realization that ectopically
expressed TRPC proteins also make Ca2+ permeable cation
channels, in most cases activated downstream of PLC
stimulation, brought about the belief that these proteins could
function as the long-sought SOCs. Consequently, most, if not all
studies aimed to elucidate the molecular nature of SOCs focused
on mammalian TRPC proteins. However, rather than illumi-
nating, the resultant literature provided controversial evidence
for each of the TRPC proteins as well as for TRPV6 and
TRPM3, either in favor of or refuting a role as SOCs. To
illustrate this controversy, an overview of the major findings
regarding the role of TRPs as SOCs is provided below (for a
thorough discussion, see [86,102,136,140]).
5.1. TRPCs
The TRPC family contains the mammalian genes most
closely related to the Drosophila trp gene [145,159]. Based on
structural similarities the TRPC family is divided into four
subgroups: TRPC1; TRPC2; TRPC3, 6 and 7; and TRPC4 and5. TRPC3, 6 and 7 not only share a high degree of amino acid
identity but also functional and regulatory similarities. A
structural, and possibly functional relationship also exists
between TRPC4 and 5. TRPC2, a pseudo gene in humans and
old world primates, forms functional channels in mouse, rat and
other mammalian species [161,162]. The reader is referred to a
recent review for a comprehensive discussion of structure–
function relationships of TRPC channel proteins [140].
The notion that TRPC1 and 4 may form, or be part of SOCs
is supported mainly by two different lines of experimental
evidence. First, ectopic expression of TRPC1 or 4 in several cell
lines increases endogenous store-operated entry induced by
either PLC-dependent or pharmacologically-induced depletion
of ER Ca2+ stores [36,61,91,144,160]. Second, the use of
antisense constructs directed against TRPC1 or 4, as well as
genetic disruption of the corresponding genes, has efficiently
reduced store-operated entry in a variety of cell types
[18,19,61,126,132,150,152]. In some instances, those protocols
produced a significant reduction of the archetypical store-
operated current ICRAC [35,78,93], leading to the conclusion
that TRPC1 or 4 are part of native CRAC channels. However,
the question remains if the decrease in ICRAC was directly
caused by an actual reduction in TRPC1 or 4 protein levels,
rather than being the result of compensatory changes in the
expression of CRAC channel subunits or regulatory proteins. It
is noteworthy that the focused and whole genome screens
described above that brought the roles of Stim1 and Orai1 to
light [33,59,110,143,156] apparently failed to detect any TRP
channels. Moreover, neither TRPC1 nor TRPC4 recapitulate the
biophysical properties expected for CRAC channels when
ectopically expressed in cell lines. Despite the evidence
mentioned above, the role of TRPC4 in store-operated entry
has not yet received as much consensus as for TRPC1 (see
[3,95] and references therein). This is mainly due to the
controversy raised by several studies showing that ectopic
expression of mouse TRPC4 in diverse cell lines results in the
appearance of PLC-regulated cation channels whose activity is
completely independent of Ca2+store depletion [80,113,158].
Also, in HEK293 cells, a human epithelial cell line, ectopically
expressed human TRPC4 rendered constitutively active chan-
nels not regulated by agonist or Ca2+ store-depletion [71].
Evidence for store-operated regulation of mouse TRPC5 is
limited, and published results are controversial (cf. [92] and
[82]). In most instances TRPC5 activation, although down-
stream of receptor stimulation of PLC, seems not to be related to
Ca2+ store-depletion [95,113]. A more recent report however,
showed that at the single cell level TRPC5 may possibly be
activated by a variety of signals, including depletion of Ca2+
stores [155]. It is conceivable that the disparate channel
behavior, in terms of sensitivity to store depletion, could be
influenced by the expression conditions (see below).
Ectopic expression of a splice variant of mouse TRPC2,
designated TRPC2A,was shown to enhance store-operated Ca2+
entry in monkey kidney fibroblast-like cells [138]. However, a
different lab cloned two additional splice variants (named
TRPC2α and TRPC2β) [44], and showed that neither these
variants nor TRPC2A were able to form channels operated by
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conflict with a role for mouse TRPC2 as a SOC. Conversely,
native TRPC2 has been reported to take part in endogenous
store-operated entry in Chinese hamster ovary cells [37] and
spermatic cells [49].
TRPC3 constitutes an inveterate example of the existing
controversy as to whether or not a particular TRPC channel can
function in a store-operated manner. Some of the confusion
regarding the ability of TRPC3 to function in a store-operated
mode stems from the fact that, when ectopically expressed,
TRPC3 constitutes a channel endowed with significant consti-
tutive activity. This makes it difficult to distinguish a genuine
store-dependent effect from mere enhanced constitutive activity,
particularly in experiments where Ca2+ entry is monitored by
means of fluorescent Ca2+ indicators (discussed in [100,136]).
Despite compelling evidence supporting the view that the
signaling to TRPC3 is downstream of receptor-dependent
activation of PLC but in a manner not related to Ca2+ store
depletion (reviewed in [136,140]), studies by Kiselyov et al.
[51,52] advocating that TRPC3 channels are indeed store-
operated, challenged that view. These studies showed that stable
expression of TRPC3 in HEK293 cells results in a non-selective
cation channel activated either by stimulation of a Gq-coupled
muscarinic receptor or by pharmacological depletion of Ca2+
stores, in both instances in an IP3R-dependent fashion. In
contrast, Trebak et al. [134] showed that in two different clones
of TRPC3-expressing HEK293 cells, including the one used in
the studies by Kiselyov et al. [51,52], TRPC3 behaves as a ROC
independently of Ca2+ store depletion or the IP3R. A possible
explanation for these disparate results regarding the store-
dependence/independence of TRPC3 channels derives from
recent studies by Vazquez et al. [139,142], showing that in the
avian B-lymphocyte DT40 cell line ectopic expression of
TRPC3 resulted in a channel whose ability to function in either
receptor- or store-operated modes was clearly related to channel
expression level (discussed in detail in [101]). Store-operation
was observed only at very low channel expression levels,
whereas conditions that resulted in higher levels of TRPC3
protein expression gave rise to the receptor-regulated mode of
TRPC3 activation.
TRPC7 was originally shown to function as a PLC-regulated
channel when expressed in HEK293 cells [83], presumably
through PLC-derived DAG, but subsequent evidence indicated
that it can also function as a SOC [107]. Notably, recent work
revealed that these apparently conflicting findings stem from the
ability of TRPC7 to operate in either store-operated or receptor-
activated modes depending, as for TRPC3, upon the protein
expression level [56]. In those studies, Lievremont et al. [56]
showed that transient expression of TRPC7 in HEK293 cells
rendered a DAG-activated channel, but when expressed stably, it
behaved as a SOC. In an attempt to determine which of these two
coupling modes corresponds to the physiological function of
endogenously expressed TRPC7, a follow up study [57] utilized
targeted homologous recombination to knock out TRPC7 in
DT40 B-lymphocytes, known to express endogenously both
store-operated and non-store-operated pathways [87,125,141].
In what represented the first demonstration of a physiologicalfunction for native TRPC7, it was found that knockout of
TRPC7 in DT40 B-lymphocytes did not significantly affect
ICRAC [57]. Rather, in the avian B cell line, TRPC7 functions as a
PLC-regulated, DAG-activated non-selective cation channel. It
is possible, however, that native TRPC7 may function as a SOC
in other cell types, for instance, when SOC currents exhibit
properties reminiscent of TRPCs (see for example [137]).
As of this writing, available evidence indicates that ectopic
expression of TRPC6, either of mouse or human origin, results
in a non-selective cation channel whose activation is linked to
PLC-derived products but is independent of Ca2+ store
depletion (reviewed in [136,140], but see [22]). It should be
noted, however, that the impact of channel expression level on
TRPC6 regulation has not yet been addressed.
Evidently, despite some evidence that, at least under certain
conditions some TRP proteins may form, or be part of store-
operated Ca2+-permeable channels, the role of TRPs as genuine
SOCs is still under debate. A chronic problem in recognizing
TRPs as SOCs is the inability of ectopically expressed TRP
proteins to recapitulate ICRAC. However, it should be noted that
although ICRAC was the first store-operated Ca
2+ current
described and thus stands as the archetypical one, SOCs are
heterogeneous with respect to both cation selectivity and
pharmacological profile in different cell types (see [86] and
refs. therein). This suggests that SOC channels may comprise a
heterogeneous group of Ca2+-permeable channel proteins.
Therefore, it is reasonable to conceive that SOC currents with
different properties from ICRAC may indeed involve channels
built of TRP proteins. Within this context, it is important to note
that functional TRPC channels are thought to be formed by four
TRPC proteins that form either homo- or hetero-tetramers (see
[140] and references therein) and, regardless of limitations as to
which TRPCs can come together to form complete channels, it is
recognized that the ultimate tetramer composition can alter
functional and pharmacological features of TRPC channels
[58,60,124]. Consequently, it is likely that native SOCs result
from combinations of endogenous proteins not readily recapit-
ulated in overexpression experiments. Undoubtedly, careful
examination of the relationship between TRP protein expression
level and channel regulation, as well as more emphasis on
determining the composition of native TRP channels by taking
advantage of knock out models and/or siRNA strategies, might
eventually clarify existing discrepancies that hinder definition of
their mode of regulation. However, even in those instances
where TRP proteins have been found to be genuinely store-
operated, the underlying mechanism coupling store-depletion to
channel activation remains unknown. Within that context, in
view of the recent discovery that the mammalian Ca2+-binding
protein STIM1 (see Section 4.1 above) plays an essential role in
the activation of SOCs, likely by acting as the sensor of Ca2+
store content [59,110], upcoming studies should address the
potential role of STIM1 in regulation of store-operated TRPs.
6. Role of store-operated entry in [Ca2+]i Oscillations
[Ca2+]i oscillations, which generally consist of a series of
repetitive spikes of [Ca2+]i, represent the physiological response
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Agonist-induced oscillations usually occur as a result of PLC
activation followed by the production of IP3 and the repetitive
release of Ca2+ from internal stores. At high agonist concentra-
tions, it is widely accepted that SOCs are responsible for refilling
the ER following store depletion [86,98]. However, the
particular role that SOCs play in [Ca2+]i oscillations, which
occur at submaximal agonist concentrations and involve only a
modest depletion of stores, is still a matter of debate.
Since the behavior of Ca2+ oscillations varies among
different cell types as well as the type of agonist used, it is
often difficult to resolve the complex relationship between
oscillations and pool depletion. In many cell types, oscillations
are abolished when Ca2+ is removed from the extracellular
medium, suggesting that Ca2+ entry across the plasma
membrane is necessary to maintain them [12,109,129,149]. It
has been proposed that this may be achieved through the action
of store-operated entry [5,129]. Conversely, Shuttleworth has
provided evidence that agonist-induced oscillations are not
mediated by SOCs, but involve Ca2+ entry channels regulated
by lipid second messengers derived from products of PLC or
PLA2 [116]. Others have shown that other non-store operated
channels such as TRPs are involved in the maintenance of
oscillations [40,108,133,151].
Elimination of [Ca2+]i oscillations in Ca2+-free external
solutions suggests a role for Ca2+ entry in maintaining Ca2+
oscillations, but does not provide information on the precise
nature of the Ca2+ entry pathway. In light of this, there is
pharmacological evidence to support the involvement of store-
operated entry. In one study, hormone-induced oscillations in
hepatocytes were inhibited by Gd3+, 2-APB, and SK & F
96365, all at concentrations that inhibit SOCs and, specifically,
ICRAC [38,39]. In this same study, LOE-908, which blocks non-
store operated channels, did not affect oscillations. Others have
shown that La3+, another inhibitor of SOCs, blocks agonist-
induced oscillations in cortical astrocytes [94]. In other studies
using similar pharmacological tools, there is evidence that
SOCs mediate oscillations in lymphocytes, HEK293 cells, and
myotubes [12,28,55]. Whether entry through SOCs initiates or
maintains IP3-mediated Ca
2+ oscillations remains unclear,
especially since the molecular identity of the SOCs involved
is unknown.
Despite the growing body of evidence to support the role that
SOCs play in the maintenance of [Ca2+]i oscillations, arguments
have been raised against their involvement based on two
observations. Shuttleworth and colleagues [116,117] maintain
that agonist-induced oscillations are predominantly dependent
on the generation of AA, a pathway that is activated
independently of store depletion. In reports using HEK293
cells that overexpress the M3 muscarinic receptor and
pancreatic acinar cells, addition of isotetrandrine, a phospho-
lipase A2 blocker, inhibited the carbachol-induced oscillatory
response [74,75]. Moreover, Shuttleworth and colleagues report
that with high agonist concentrations, ARC channel activity is
lost and the mode of Ca2+ entry occurs primarily through SOC
activation, a phenomenon termed “reciprocal regulation” [74].
A similar reciprocal relationship between arachidonic acid-activated and store-operated entry was described by Luo et al.
[62] and by Moneer et al. [76].
TRP channels, which are associated with both SOC and
ROC entry, have also been implicated in the maintenance of
oscillations. One study identified a role for DAG-sensitive
TRPC3 activation in the initiation of oscillations in glial cells
[40]. OAG (1-oleoyl-2-acetyl-sn-glycerol; a synthetic DAG
analog) -induced oscillations were preserved when external
Ca2+ was replaced with Sr2+, providing further evidence for
TRPC channel involvement since these channels are more
permeable to Sr2+ cations than are SOCs. In another study
using antisense technology to silence endogenous TRPC4,
carbachol-induced oscillations were damped in HEK-293 cells
in a manner similar to the run-down of oscillations in wild type
HEK293 cells in Ca2+-free conditions [151].
The information encoded by [Ca2+]i oscillations has been
shown to control a variety of processes including gene
transcription, muscle contraction, and differentiation. Hence,
it is of great importance to elucidate the mechanisms underlying
their initiation and maintenance. The Ca2+ entry during IP3-
mediated oscillations is difficult to resolve since the release
from stores is small. However, in many cell types, oscillations
abruptly cease or gradually run down when Ca2+ is removed
from the external environment, making it clear that entry from
the outside is a necessary component in this type of signaling
process [42]. With the recent findings that STIM1 and Orai1
play an essential role in ICRAC regulation (see above), these gene
products may provide further clues as to the regulation of
agonist-induced oscillations.
7. Pathophysiology associated with store-operated entry
Channelopathies are commonly the direct cause of disease,
or contribute indirectly to the development of a disease.
Knowing the extreme importance of SOC and CRAC channel
activities in a variety of physiological functions, one would
expect to see a pathophysiological phenotype if impaired store-
operated entry occurred. The only documented disease state
directly associated with a dysfunction in store-operated entry is
a hereditary form of SCID syndrome [30,32,33]. SCID refers to
a family of pathologies characterized by a malfunction in T and
or B-lymphocyte activation and may be caused by a number of
molecular abnormalities including mutations in cell surface
receptors, signal transduction molecules, and transcription
factors [27]. Regardless of the etiology of the condition,
SCID patients share in common a hypersensitivity to infection
due to compromised immune function. The form of SCID that is
related to a dysfunction of store-operated entry was first
attributed to a defect in nuclear import of the transcription factor
NFAT in T-lymphocytes derived from affected patients [30]. In
T-lymphocytes from normal individuals, presentation of an
antigen causes a series of synchronized events, including the
production of IP3 and release of Ca
2+ from the ER. This release
of Ca2+ from the internal stores triggers influx of Ca2+ through
CRAC channels, and this Ca2+ influx activates, via calmodulin,
the phosphatase calcineurin which in turn dephosphorylates
NFAT and induces nuclear import of the transcription factor
Fig. 1. Proposed model of regulation of store-operated Ca2+ entry by STIM1 and
Orai1. Agonist (Ag) stimulation of plasma membrane receptors (R) induces PLC
activity, the products of which can directly activate Ca2+ entry via TRPC chan-
nels in a receptor-operated fashion. Further, IP3 generated by PLC induces
release of Ca2+ from the ER via the IP3R. STIM1, located within the ER
membrane, senses ER Ca2+ depletion and translocates toward the plasma mem-
brane, where it interacts with and activates Orai1, the putative CRAC channel. It
remains to be determined whether STIM1 also regulates other store-dependent
entry pathways, such as those mediated by store-operated TRPC channels.
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from patients suffering from this hereditary form of SCID
completely lack ICRAC [32]. Further, it was recently shown
using a combination of two unbiased genome-wide approaches
that a missense mutation, whereby a conserved arginine residue
is replaced with a tryptophan at position 91 of the Orai1 gene, is
responsible for the defect in ICRAC in these patients [33]. Thus,
not only has this series of studies with SCID patients led to the
discovery of the molecular basis of a rare and debilitating
disease, it has also proven instrumental in the discovery of a
critical factor, Orai1, involved in the regulation of ICRAC.
There is also evidence for a role of store-operated entry in
diverse disease states such as acute pancreatitis [104] and
Alzheimer's disease [70,72,154], as well as a possible role in
causing some of the toxic effects of environmental chemicals
that alter Ca2+ homeostasis [86]. Furthermore, there are to date
four known channelopathies directly associated with TRP
channels [79]. Three of these channelopathies involve
TRPM6, TRPP2, and TRPML1, which have no known
functions in store-operated entry. However, of particular
interest to this discussion is the finding that TRPC6 is
essential in the regulation of renal podocyte structure and
function, and that a mutation in this channel that results in
larger TRPC6 currents leads to proteinuria followed by
progressive kidney failure [105,147]. However, as stated
earlier, there is as yet no evidence to indicate that TRPC6 can
function as a SOC under any conditions; therefore, it is not
clear whether this defect in TRPC6 reflects a dysfunction in
store-operated entry.
8. Conclusions
It has been 20 years since the commencement of study of
store-operated Ca2+ entry pathways. And in that time, an
extensive literature addressing properties of various SOC
currents, pharmacological and cell biological properties of
SOCs, and physiological and pathophysiological roles for
store-operated entry has developed. However, until the very
recent identification of roles for STIM1 and Orai1 in
physiological ICRAC, the field has suffered from a lack of
unequivocal identification of molecular components of store-
operated entry pathways. Thus, these are exciting times for the
field of store-operated Ca2+ influx. The immediate challenge is
of course to precisely define the mechanisms by which STIM1
and Orai1 regulate ICRAC, as well as possibly other store-
dependent entry pathways (Fig. 1). But beyond that, we are
also faced with the task of revisiting much of this literature
that has accumulated over the past 20 years in order to
determine how the known functions of STIM1 and Orai1 may
help address some of the outstanding, unresolved issues. For
example, does STIM1 function as a universal Ca2+ sensor,
capable of activating mechanisms of store-operated entry other
than ICRAC? And if Orai1 is indeed the CRAC channel, then
how do molecular determinants within the protein sequence
explain the electrophysiological properties of ICRAC such as
permeation and ionic selectivity? Answers to these questions
and many more will significantly enhance our understandingof cellular Ca2+ signaling and its contribution to normal
human health and disease.References
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